| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Pramoda Anita is a Director at HCAT, with reported holdings spanning 3 companies. Recent filings cover 1 purchase and 15 sales. Those positions are worth an estimated $223K at current prices.
Our model assigns Pramoda Anita a middling insider score of 53/100, based on 3 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +20.3%.
Pramoda Anita's largest disclosed position is in GOCO as Director, worth about $223K. Net of sales, the recent Form 4 record there shows accumulation of 10,370 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2021 | HCAT Health Catalyst, Inc. | - | Sell | 5,443 | $56.53 | $307,698.89 | -62.4% | -2.4% | -77.7% | |
| Jun 1, 2021 | HCAT Health Catalyst, Inc. | Director | Sale+OE | 6,848 | $53.52 | $366,528.93 | -63.1% | -1.3% | -73.9% | |
| Mar 12, 2021 | GOCO Gohealth, Inc. | Director | Buy | 10,370 | $9.99 | $103,596.30 | +87.1% | -1.6% | -90.6% | |
| Jan 15, 2021 | HCAT Health Catalyst, Inc. | Director | Sale+OE | 34,000 | $48.06 | $1,634,205.81 | -86.2% | - | - | |
| Dec 17, 2020 | HCAT Health Catalyst, Inc. | Director | Sale+OE | 34,000 | $42.04 | $1,429,411.00 | -86.2% | - | - | |
| Dec 7, 2020 | HCAT Health Catalyst, Inc. | Director | Sale+OE | 34,000 | $38.13 | $1,296,451.60 | -80.3% | - | - | |
| Sep 10, 2020 | HCAT Health Catalyst, Inc. | Director | Sell | 34,000 | $34.18 | $1,161,963.60 | -52.8% | - | - | |
| Aug 14, 2020 | HCAT Health Catalyst, Inc. | Director | Sell | 4,000 | $31.46 | $125,841.00 | -6.2% | - | - | |
| Jul 15, 2020 | HCAT Health Catalyst, Inc. | Director | Sell | 30,000 | $36.20 | $1,085,913.00 | -31.8% | - | - |